Syapse is a healthcare technology company dedicated to extinguishing the fear and burden of serious disease by advancing real-world data.

I started consulting for Fletcher Payne in spring of 2021 focusing on capital markets and corporate development topics. After position of VP Finance opened up, I spent working with Syapse 2 years full-time and delivered the following results:

• Implemented a cost-saving program that reduced the operating expense by $15 million
• Raised $35 million growth funding round amid challenging market conditions
• Rebuilt financial planning, analysis (FP&A), budgeting, modelling, and forecasting function

Examples of my previous consulting engagements include:

Pacific Biosciences is a genome sequencing equipment manufacturer with a market cap $3bn as of the end of 2020

• Developed the long-term strategy for genome sequencing equipment

• Assessed addressable markets (TAM / SAM / SOM)

• Built a 5-year financial model to support the strategic planning process

• Created a financial model for the partnership with Invitae announced in January 2021

Bestow is an insurtech company that sells term life insurance online.

• Built a 5-year financial model to support series D capital raise

VIA is an early stage fintech startup developing a financial management tool for small and medium sized businesses

• Created a 5 year financial model and detailed 12 month budgets

• Developed investor presentation and data room

• Reached out to Venture Capital firms regarding a potential capital raise

• Developed a customized financial modelling course for a group of 25 people primarily from the corporate development department

• Advanced topics such as scenario modelling, LBO and valuation

Research on Ignition Interlock Devices

Research on Genomics

Research on Healthcare IT technologies